BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with no assurance regarding its timing, size, or terms.
Proceeds from the offering will be used for purchasing gold bullion, working capital, and general corporate purposes.
Offering Details
Shares of common stock to be offered through underwritten public offering.
Use of Proceeds
Intends to use net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering remains subject to market conditions with uncertainty regarding timing, size, and terms.
- The offering is being made pursuant to a shelf registration statement declared effective by the SEC.
- Interested parties are advised to read the relevant documents for more information about the Company and the offering.
BioSig Technologies Inc. is moving forward with a proposed public offering to support its strategic objectives and financial requirements. The involvement of Clear Street and Needham & Company as book-running managers highlights the significance of this offering.